# Viatris Inc. – FDA Inspection, Aug 18, 2023

Source: https://www.keypedia.com/records/fda_inspections/viatris-inc/f27e7a90-3421-42b9-a6ea-e1d6f4ec77ae
Source feed: FDA_Inspections

> FDA inspection 1219018 of Viatris Inc., August 18, 2023. Classification: No Action Indicated (NAI). 21 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219018
- Company Name: Viatris Inc.
- Inspection Date: 2023-08-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1302530 - 2026-08-28
- FDA Inspection 1311680 - 2026-04-28
- FDA Inspection 1170444 - 2022-05-26
- [FDA Inspection 1099590 - 2019-08-15](https://www.keypedia.com/records/fda_inspections/viatris-inc/ce0dbe8c-6a9e-4ed3-ac81-5c9508c700af)
- [FDA Inspection 1097589 - 2019-07-25](https://www.keypedia.com/records/fda_inspections/viatris-inc/73c177da-f9fd-4e65-a8aa-55745cfaf565)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/anastasia-i-onuorah/d081d002-e4a4-4001-ba06-b71ff9fbf9f7)

Company: https://www.keypedia.com/companies/viatris-inc/e65d242e-4279-4e07-992f-5f241792c2cf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
